Table 3 Predictors of 6-month mortality in patients aged 50–74 years
Variables | Chinese cohort | P value | Swedish cohort | P value |
|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||
Age | 0.957 (0.914–1.003) | 0.066 | 1.110 (1.047–1.177) | < 0.001 |
Female | 1.079 (0.572–2.035) | 0.815 | 1.565 (0.869–2.816) | 0.135 |
SBP (per 10 mmHg) | 0.876 (0.717–1.071) | 0.198 | 0.818 (0.699–0.956) | 0.012 |
Heart rate (per 10 beats/min) | 0.983 (0.834–1.160) | 0.841 | 1.211 (0.992–1.479) | 0.060 |
Ischemic etiology | 1.248 (0.553–2.813) | 0.594 | 1.002 (0.558–1.799) | 0.994 |
Atrial fibrillation/flutter | 1.278 (0.696–2.348) | 0.428 | 0.917 (0.515–1.633) | 0.769 |
Diabetes mellitus | 0.936 (0.489–1.791) | 0.841 | 1.005 (0.573–1.763) | 0.987 |
Anemia | 1.209 (0.656–2.228) | 0.543 | 1.657 (0.944–2.908) | 0.079 |
QRS ≥ 120 ms | 1.297 (0.658–2.558) | 0.452 | 1.854 (1.038–3.310) | 0.037 |
NT-proBNP (per 100 pg/mL) | 1.006 (1.003-1.008) | < 0.001 | 1.003 (1.000-1.007) | 0.031 |
LVEF < 40% | 1.083 (0.540–2.173) | 0.822 | 1.075 (0.598–1.933) | 0.809 |
eGFR | 0.986 (0.973–0.999) | 0.033 | 0.988 (0.976–0.999) | 0.043 |
ACEIs/ARBs | 0.935 (0.485–1.803) | 0.841 | 1.172 (0.475–2.888) | 0.730 |
Beta-blockers | 0.537 (0.284–1.016) | 0.056 | 1.007 (0.368–2.753) | 0.990 |
Aldosterone antagonists | 0.874 (0.449–1.702) | 0.692 | 0.570 (0.308–1.054) | 0.073 |